- Horizon Scanning Case Study: Developing standards for Adeno-associated virus gene therapies
- Anyone with Prenoxad (naloxone) injection kits must check for missing needles
- Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator
- Every report to MHRA’s Yellow Card scheme helps improve the safety of medicines and medical devices for all
- Patients urged to check packs of Targocid 200mg after two batches found to be contaminated
- London medicines wholesaler sentenced for illegally importing and distributing over £2.9m of medicines
- Unique opportunity for healthcare professionals to influence future MHRA safety communications and safety reporting systems
- Mental health funding of £1.8m welcomed by MHRA and NICE to explore regulation of digital mental health tools
- MHRA response to contaminated paediatric medicines identified in WHO region of Africa
- European Commission Decision Reliance Procedure (EC DRP) extension
- MHRA appoints first new UK Approved Body to certify medical devices since Brexit
- MHRA launches new conflicts of interest code of practice for independent advisors
- No change to MHRA advice on the safety and effectiveness of COVID-19 vaccines for those who are pregnant or breastfeeding
- Pfizer/BioNTech bivalent COVID-19 booster approved by UK medicines regulator
- Novavax COVID-19 vaccine approved for 12 to 17s by MHRA
TSET - Technical Specialist Education and Training Group
News and communications from MHRA
By TSETadmin